AUTL
Autolus Therapeutics
AUTL
AUTL
38 hedge funds and large institutions have $558M invested in Autolus Therapeutics in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
3.71% less ownership
Funds ownership: 46.02% → 42.31% (-3.7%)
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Holders
38
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$36.1M | |
| 2 | +$6.5M | |
| 3 | +$3.96M | |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$323K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$322K |
Top Sellers
| 1 | -$40.7M | |
| 2 | -$6.74M | |
| 3 | -$4.73M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.06M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$2.58M |